Inhibition of intimal lipid deposition in human apolipoprotein A1 transgenic mice

Citation
Mp. She et al., Inhibition of intimal lipid deposition in human apolipoprotein A1 transgenic mice, CLIN EXP PH, 26(10), 1999, pp. 833-834
Citations number
3
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
ISSN journal
03051870 → ACNP
Volume
26
Issue
10
Year of publication
1999
Pages
833 - 834
Database
ISI
SICI code
0305-1870(199910)26:10<833:IOILDI>2.0.ZU;2-Q
Abstract
1. Southern blot confirmed the emergence of the human apolipoprotein A1 (h- apoA1) gene (four to 15 copies) in newborn transgenic mice. The inheritance pattern of h-apoA1 transgene in three generations of progeny was compatibl e with a single autosomal integration site. 2. Northern blot showed h-apoA1 mRNA expressed mainly in liver, kidney and aorta, The total plasma apoA1 (murine plus human) level was significantly i ncreased to 58 and 118 in transgenic mice without or under zinc induction, respectively. The majority was h-apoA1. Plasma lecithin:cholesterol acyltra nsferase activity was positively correlated with h-apoA1 levels in transgen ic mice (r = 0.43; P < 0.01). 3. After a high cholesterol intake for 14 weeks, the incidence of fatty str eak at the aortic sinus was 40% in transgenic mice and 80% in controls. Exp ression of platelet-derived growth factor-B, c-myc and c-fos proteins was m uch weaker in smooth muscle cells at the aortic sinus in transgenic mice.